Evidence map›Paper›PMID 35726719›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2022

FabT, a Bacterial Transcriptional Repressor That Limits Futile Fatty Acid Biosynthesis.

Clara Lambert, Claire Poyart, Alexandra Gruss, Agnes Fouet

Open access · greenAbstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Live and heat-treatediScience · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Emergence of multidrug-resistant ST876 serotype 14Frontiers in cellular and infection microbiology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Heterogeneous subpopulations inFrontiers in cellular and infection microbiology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Antimicrobial agents and chemotherapy · 2024
    Article
  17. Article
  18. Article
  19. Acyl-AcpB, a FabT corepressor inJournal of bacteriology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Clara LambertUniversité Paris Cité, Institut Cochingrid.462098.1, INSERM, U1016, CNRS, UMR8104, Paris, France.
Claire PoyartUniversité Paris Cité, Institut Cochingrid.462098.1, INSERM, U1016, CNRS, UMR8104, Paris, France.
Alexandra Gruss *Micalis Institute, INRAE, AgroParisTech, Université Paris-Saclay, Jouy en Josas, France.ORCID 0000-0001-7426-5229
Agnes Fouet *Université Paris Cité, Institut Cochingrid.462098.1, INSERM, U1016, CNRS, UMR8104, Paris, France.ORCID 0000-0001-7715-9157
Centre National de la Recherche Scientifique · FRAgroParisTech · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phospholipids are vital membrane constituents that determine cell functions and interactions with the environment. For bacterial pathogens, rapid adjustment of phospholipid composition to changing conditions during infection can be crucial for growth and survival. Fatty acid synthesis (FASII) regulators are central to this process. This review puts the spotlight on FabT, a MarR-family regulator of FASII characterized in streptococci, enterococci, and lactococci. Roles of FabT in virulence, as reported in mouse and nonhuman primate infection models, will be discussed. We present FabT structure, the FabT regulon, and changes in FabT regulation according to growth conditions. A unique feature of FabT concerns its modulation by an unconventional corepressor, acyl-acyl-carrier protein (ACP). Some bacteria express two ACP proteins, which are distinguished by their interactions with endogenous or exogenous fatty acid sources, one of which causes strong FabT repression. This system seems to allow preferred use of environmental fatty acids, thereby saving energy by limiting futile FASII activity. Control of

Indexed as

Acyl Carrier ProteinBacterial ProteinsFatty AcidsTranscription FactorsAnimalsBacteriaCo-Repressor ProteinsGene Expression Regulation, BacterialMicePhospholipidsVirulenceAcyl Carrier ProteinBacterial ProteinsCo-Repressor ProteinsFatty AcidsPhospholipidsTranscription Factorsacyl-ACPbinding sitesFabTfatty acid synthesisfeedback regulationrepressor

Identifiers

PMID35726719
PMCPMC9491164
OpenAlexW4283220005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.